Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.68B | 19.40B | 18.90B | 17.82B | 15.36B | 13.06B |
Gross Profit | 3.37B | 3.77B | 3.93B | 3.12B | 2.64B | 1.72B |
EBITDA | 2.51B | 4.21B | 3.42B | 2.34B | 2.19B | 1.26B |
Net Income | 1.06B | 2.18B | 1.66B | 745.00M | 1.19B | 132.78M |
Balance Sheet | ||||||
Total Assets | 16.21B | 19.22B | 17.76B | 16.85B | 15.55B | 14.25B |
Cash, Cash Equivalents and Short-Term Investments | 2.50B | 4.19B | 3.90B | 2.53B | 1.85B | 1.40B |
Total Debt | 3.07B | 1.45B | 1.95B | 2.50B | 2.53B | 2.95B |
Total Liabilities | 6.31B | 5.06B | 5.45B | 6.10B | 5.39B | 5.20B |
Stockholders Equity | 9.90B | 14.15B | 12.32B | 10.75B | 10.15B | 9.05B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.09B | 2.13B | 588.00M | 986.23M | -277.61M |
Operating Cash Flow | 0.00 | 3.22B | 3.38B | 2.52B | 1.84B | 635.35M |
Investing Cash Flow | 0.00 | -2.26B | -1.28B | -1.82B | -784.90M | -905.44M |
Financing Cash Flow | 0.00 | -663.00M | -722.00M | -19.00M | -961.10M | -532.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥19.27B | 4.14 | 2.76% | 5.07% | 24.88% | ||
79 Outperform | ¥13.79B | 6.32 | 4.29% | 2.62% | 31.70% | ||
74 Outperform | $154.06B | 6.60 | 10.52% | 3.94% | 4.65% | 11.70% | |
72 Outperform | ¥59.67B | 27.06 | 0.52% | 13.62% | 24.54% | ||
70 Outperform | ¥28.04B | 19.80 | 0.87% | -0.54% | -13.51% | ||
68 Neutral | ¥197.59B | 21.29 | 8.29% | 2.34% | 5.00% | 2.97% | |
65 Neutral | ¥50.48B | 12.77 | 2.80% | 1.11% | ― |